Merz Aesthetics, the world’s largest dedicated medical aesthetics business, has launched flagship products XEOMIN (incobotulinumtoxinA) and RADIESSE in China. With this expansion into the world’s fastest-growing market, Merz Aesthetics continues to extend the reach of its comprehensive injectables portfolio.
“China is a key strategic market for our global business, and this milestone reflects our incredible momentum as a category leader,” said Bob Rhatigan, CEO, Merz Aesthetics. “Since becoming a standalone business in 2020, we have consistently outpaced the growth in our industry, and we remain committed to increasing access to our premium products across the world.”
The launch gives patients in China access to the high standards for innovation, quality, safety and patient-centric benefits that XEOMIN and RADIESSE offer.
- XEOMIN is the first and only double-purified toxin that uses XTRACT Technology™ to eliminate unnecessary ingredients, leaving only the active neurotoxin with two supporting ingredients that are not immune triggering. Xeomin has shown zero toxin resistance in pivotal clinical studies.
- As the number one researched biostimulator in Regenerative Aesthetics publications, RADIESSE’s high quality microspheres activate via non-inflammatory pathways. RADIESSE utilizes an ingredient that is also naturally found in your body to activate your skin’s regenerative power- boosting collagen, elastin, and other key proteins. It has been shown to stimulate up to 23 times more collagen and 96% more elastin.
“China’s medical aesthetics community is rapidly evolving, and we are honored to support customers and their patients with advanced, clinically proven solutions for their dynamic needs,” said Lawrence Siow, President of Merz Aesthetics Asia Pacific. “Our commitment in China goes beyond products. We invest in education, training and true partnerships to help practitioners deliver customized results and empower patients to feel confident.”
Merz Aesthetics exists to fuel confidence by helping people look better, feel better and live better around the world. Findings from its recent Pillars of Confidence Global Study reinforce the cultural embrace of aesthetics in China, with 68% of study respondents saying they have had an aesthetic treatment, versus 35% of U.S. respondents. As a premier business partner to customers and their patients, Merz Aesthetics combines the latest technology with top-tier education and training to support customers in their drive to help their patients achieve the outcomes they want.
